Operating
Benefit from Receivables
Medline, Inc. Benefit from Receivables decreased by 96.2% to $1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 96.2%, from $26.00M to $1.00M.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2023
Last reportedQ1 2026May 6, 2026
Metric ID:
csco_benefit_from_receivablesHistorical Data
10 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $2.00M | $2.00M | $2.00M | $15.75M | $15.75M | $15.75M | $15.75M | $26.00M | $1.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +687.5% | +0.0% | +0.0% | +0.0% | +65.1% | -96.2% |
| YoY Change | — | — | — | — | +687.5% | +687.5% | +687.5% | +687.5% | +65.1% | -96.2% |
Range$1.00M – $26.00M
CAGR-26.5%
Avg YoY Growth+453.2%
Median YoY Growth+687.5%
Benefit from Receivables at Other Companies
Frequently Asked Questions
- What is Medline, Inc. 's benefit from receivables?
- Medline, Inc. (MDLN) reported benefit from receivables of $1.00M in Q1 2026.
- How has Medline, Inc. 's benefit from receivables changed year-over-year?
- Medline, Inc. 's benefit from receivables decreased by 96.2% year-over-year, from $26.00M to $1.00M.